Artwork

Content provided by Bio-Techne. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Bio-Techne or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Alessio Ciulli: At the Forefront of Targeted Protein Degradation

55:02
 
Share
 

Manage episode 441697600 series 3603216
Content provided by Bio-Techne. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Bio-Techne or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Alessio Ciulli is a Professor and Chair of Chemical Structural Biology at the University of Dundee, where he is also the founder and director of the Centre for Targeted Protein Degradation (CeTPD). He is also the scientific founder of Amphista Therapeutics. This conversation covers the significant moments in Alessio’s career where he began to shape an exciting new approach in drug discovery: targeted protein degradation.

CeTPD page: https://www.dundee.ac.uk/cetpd

Alessio’s group page: https://www.dundee.ac.uk/people/alessio-ciulli

Alessio’s Twitter: https://twitter.com/alessiociulli

  continue reading

14 episodes

Artwork
iconShare
 
Manage episode 441697600 series 3603216
Content provided by Bio-Techne. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Bio-Techne or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Alessio Ciulli is a Professor and Chair of Chemical Structural Biology at the University of Dundee, where he is also the founder and director of the Centre for Targeted Protein Degradation (CeTPD). He is also the scientific founder of Amphista Therapeutics. This conversation covers the significant moments in Alessio’s career where he began to shape an exciting new approach in drug discovery: targeted protein degradation.

CeTPD page: https://www.dundee.ac.uk/cetpd

Alessio’s group page: https://www.dundee.ac.uk/people/alessio-ciulli

Alessio’s Twitter: https://twitter.com/alessiociulli

  continue reading

14 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play